The hallucinogen d -lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT 1A , D 2 and TAAR 1 receptors

Intracellular and extracellular electrophysiology of nigral dopaminergic neurons—1. Identification and characterization

Grace, A. A., & Bunney, B. S. (1983) · Neuroscience · doi:10.1016/0306-4522(83)90135-5 · Cited by 937 · see citing works

Trace amines: Identification of a family of mammalian G protein-coupled receptors

Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912 · see citing works

Evidence for dopamine receptor stimulation by apomorphine

Andén, N., Rubenson, A., Fuxé, K., & Hökfelt, T. G. M. (1967) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1967.tb09604.x · Cited by 908 · see citing works

Raphe unit activity in freely moving cats: correlation with level of behavioral arousal.

Trulson, M., & Jacobs, B. (1979) · Brain Research · doi:10.1016/0006-8993(79)90157-4 · Cited by 815 · see citing works

Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis

Gobbi, G., Bambico, F. R., Mangieri, R. A., Bortolato, M., Campolongo, P., Solinas, M., Cassano, T., Morgese, M. G., Debonnel, G., Duranti, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509591102 · Cited by 676 · see citing works

The Role of Serotonin in Antipsychotic Drug Action

Meltzer, H. M. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00046-9 · Cited by 664 · see citing works

Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor

Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651 · see citing works

Substantia nigra/ventral tegmental reward prediction error disruption in psychosis

Murray, G. K., Corlett, P. R., Clark, L., Pessiglione, M., Blackwell, A. D., Honey, G., Jones, P. B., Bullmore, E. T., Robbins, T. W., & Fletcher, P. C. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002058 · Cited by 532 · see citing works

Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices

VanderMaelen, C. P., & Aghajanian, G. K. (1983) · Brain Research · doi:10.1016/0006-8993(83)90011-2 · Cited by 499 · see citing works

D1 and D2 dopamine receptor mRNA in rat brain.

Weiner, D. M., Levey, A. I., Sunahara, R. K., Niznik, H. B., O’Dowd, B. F., Seeman, P. M., & Brann, M. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1859 · Cited by 491 · see citing works

The pharmacology of lysergic acid diethylamide: A review

Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00059.x · Cited by 455 · see citing works

Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists

Baraban, J. M., & Aghajanian, G. K. (1980) · Neuropharmacology · doi:10.1016/0028-3908(80)90187-2 · Cited by 442 · see citing works

Are you or aren’t you? Challenges associated with physiologically identifying dopamine neurons

Ungless, M. A., & Grace, A. A. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.02.003 · Cited by 431 · see citing works

Modification of 5‐HT neuron properties by sustained administration of the 5‐HT1A agonist gepirone: Electrophysiological studies in the rat brain

Blier, P. U., & de Montigny, C. (1987) · Synapse · doi:10.1002/syn.890010511 · Cited by 426 · see citing works

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Revel, F. G., Moreau, J., Gainetdinov, R. R., Bradaïa, A., Sotnikova, T. D., Mory, R., Durkin, S., Zbinden, K. G., Norcross, R. D., Meyer, C. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103029108 · Cited by 366 · see citing works

Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity

Lindemann, L., Meyer, C. A., Jeanneau, K., Bradaïa, A., Ozmen, L., Bluethmann, H., Bettler, B., Wettstein, J. G., Borroni, E., Moreau, J., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132647 · Cited by 350 · see citing works

Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex

Bambico, F. R., Katz, N., Debonnel, G., & Gobbi, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-07.2007 · Cited by 325 · see citing works

Functional interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions

Guiard, B. P., Mansari, M. E., Merali, Z., & Blier, P. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008383 · Cited by 302 · see citing works

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

Revel, F. G., Moreau, J., Pouzet, B., Mory, R., Bradaïa, A., Buchy, D., Metzler, V., Chaboz, S., Zbinden, K. G., Galley, G., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.57 · Cited by 289 · see citing works

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

Grace, A. A., Bunney, B. S., Moore, H. M., & Todd, C. L. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10064-3 · Cited by 284 · see citing works

Implications of LSD and experimental mysticism

Pahnke, W. N., & Richards, W. A. (1966) · Journal of Religion and Health · doi:10.1007/bf01532646 · Cited by 254 · see citing works

The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity: TAAR1 regulation of monoaminergic activity

Miller, G. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07109.x · Cited by 249 · see citing works

The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia

Wolinsky, T., Swanson, C., Smith, K. E., Zhong, H., Borowsky, B., Seeman, P., Branchek, T., & Gerald, C. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00292.x · Cited by 245 · see citing works

Dopamine receptor binding in the corpus striatum of mammalian brain.

Burt, D. R., Enna, S. J., Creese, I., & Snyder, S. H. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.11.4655 · Cited by 220 · see citing works

Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics

Seeman, P., Ko, F., & Tallerico, T. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001682 · Cited by 200 · see citing works

Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor

Espinoza, S., Salahpour, A., Masri, B., Sotnikova, T. D., Messa, M., Barak, L., Caron, M., & Gainetdinov, R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073304 · Cited by 190 · see citing works

Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo

Allers, K. A., & Sharp, T. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00518-9 · Cited by 188 · see citing works

Lysergic acid diethylamide and 2,5-dimethoxy-4-methylamphetamine are partial agonists at serotonin receptors linked to phosphoinositide hydrolysis.

Sanders‐Bush, E., Burris, K. D., & Knoth, K. M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22189-9 · Cited by 155 · see citing works

LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.

Marek, G. J., & Aghajanian, G. K. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20792-3 · Cited by 152 · see citing works

LYSERGIC ACID DIETHYLAMIDE (LSD-25)

Savage, C. (1952) · American Journal of Psychiatry · doi:10.1176/ajp.108.12.896 · Cited by 137 · see citing works

Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis

Marona‐Lewicka, D., Thisted, R. A., & Nichols, D. E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2183-9 · Cited by 134 · see citing works

Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy

Balsara, J. J., Jadhav, J. H., & Chandorkar, A. G. (1979) · Psychopharmacology · doi:10.1007/bf00426037 · Cited by 126 · see citing works

Agonist activity of LSD and lisuride at cloned 5HT 2A and 5HT 2C receptors

Egan, C. T., Herrick‐Davis, K., Miller, K. J., Glennon, R. A., & Teitler, M. (1998) · Psychopharmacology · doi:10.1007/s002130050585 · Cited by 125 · see citing works

Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine

Kostowski, W., Gumulka, W. S., & Członkowski, A. (1972) · Brain Research · doi:10.1016/0006-8993(72)90208-9 · Cited by 125 · see citing works

Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response

Halberstadt, A. L., & Geyer, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.025 · Cited by 110 · see citing works

Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons

Gartside, S. E., Hajós‐Korcsok, É., Bagdy, E., Hársing, L. G., Sharp, T., & Hajós, M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00060-9 · Cited by 109 · see citing works

Pharmacologic Characterization of the Cloned Human Trace Amine-Associated Receptor1 (TAAR1) and Evidence for Species Differences with the Rat TAAR1

Wainscott, D. B., Little, S. P., Yin, T., Tu, Y., Rocco, V. P., He, J. X., & Nelson, D. L. G. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112532 · Cited by 109 · see citing works

Electrophysiological diversity of the dorsal raphe cells across the sleep–wake cycle of the rat

Urbain, N., Creamer, K., & Debonnel, G. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108514 · Cited by 108 · see citing works

Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists

Rasmussen, K., & Aghajanian, G. K. (1986) · Brain Research · doi:10.1016/0006-8993(86)91090-5 · Cited by 103 · see citing works

Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1

Espinoza, S., Ghisi, V., Emanuele, M., Leo, D., Sukhanov, I., Sotnikova, T. D., Chieregatti, E., & Gainetdinov, R. R. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.02.010 · Cited by 101 · see citing works

Trace Amine-Associated Receptors as Emerging Therapeutic Targets

Sotnikova, T. D., Caron, M. G., & Gainetdinov, R. R. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.055970 · Cited by 97 · see citing works

Monoamine Interactions Measured by Microdialysis in the Ventral Tegmental Area of Rats Treated Systemically with (±)‐8‐Hydroxy‐2‐(Di‐n‐Propylamino)tetralin

Chen, N., & Reith, M. E. A. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041585.x · Cited by 96 · see citing works

Evidence that central 5‐HT2A and 5‐HT2B/C receptors regulate 5‐HT cell firing in the dorsal raphe nucleus of the anaesthetised rat

Boothman, L. J., Allers, K. A., Rasmussen, K., & Sharp, T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705328 · Cited by 89 · see citing works

Engagement of the GABA to KCC2 Signaling Pathway Contributes to the Analgesic Effects of A3AR Agonists in Neuropathic Pain

Ford, A., Castonguay, A., Cottet, M., Little, J. W., Chen, Z., Symons-Liguori, A. M., Doyle, T. M., Egan, T. M., Vanderah, T. W., Koninck, Y. D., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4495-14.2015 · Cited by 86 · see citing works

Dopamine D2Highreceptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil

Seeman, P. M., Guan, H., & Hirbec, H. (2009) · Synapse · doi:10.1002/syn.20647 · Cited by 84 · see citing works

LSD and CNS Transmission

Aghajanian, G. K. (1972) · Annual Review of Pharmacology · doi:10.1146/annurev.pa.12.040172.001105 · Cited by 75 · see citing works

Lysergic Acid Diethylamide

Louria, D. B. (1968) · New England Journal of Medicine · doi:10.1056/nejm196802222780806 · Cited by 68 · see citing works

Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action

Marona‐Lewicka, D., & Nichols, D. E. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.06.001 · Cited by 64 · see citing works

Targeting of serotonin 1a receptors to dopaminergic neurons within the parabrachial subdivision of the ventral tegmental area in rat brain

Doherty, M. D., & Pickel, V. M. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1147 · Cited by 63 · see citing works

The 5-HT1A receptor and the stimulus effects of LSD in the rat

Reissig, C. J., Eckler, J. R., Rabin, R. A., & Winter, J. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0068-6 · Cited by 62 · see citing works

Molecular genetic responses to lysergic acid diethylamide include transcriptional activation of <i>MAP kinase phosphatase‐1, C/EBP‐β</i> and <i>ILAD‐1</i>, a novel gene with homology to arrestins

Nichols, C. D., & Sanders‐Bush, E. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02515.x · Cited by 62 · see citing works

Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): Discovery of EPPTB (RO5212773)

Stalder, H., Hoener, M. C., & Norcross, R. D. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.075 · Cited by 62 · see citing works

Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission

Bambico, F. R., Hattan, P. R., Garant, J.-P., & Gobbi, G. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.02.006 · Cited by 61 · see citing works

Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception.

Wallach, J. V. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.07.052 · Cited by 59 · see citing works

Electrophysiological characterization of the effects of asenapine at 5-HT1A, 5-HT2A, α2-adrenergic and D2 receptors in the rat brain

Ghanbari, R., Mansari, M. E., Shahid, M., & Blier, P. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.11.001 · Cited by 54 · see citing works

Lysergic acid diethylamide (LSD) is a partial agonist of D2 dopaminergic receptors and it potentiates dopamine-mediated prolactin secretion in lactotrophs in vitro

Giacomelli, S., Palmery, M., Romanelli, L., Cheng, C. Y., & Silvestrini, B. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00262-8 · Cited by 50 · see citing works

Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle

Domínguez-López, S., Howell, R. D., López-Canul, M., Leyton, M., & Gobbi, G. (2014) · Synapse · doi:10.1002/syn.21757 · Cited by 47 · see citing works

TAAR1-dependent effects of apomorphine in mice

Sukhanov, I., Espinoza, S., Yakovlev, D. S., Hoener, M. C., Sotnikova, T. D., & Gainetdinov, R. R. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000509 · Cited by 47 · see citing works

5-HT2A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system

Quesseveur, G., Repérant, C., David, D. J. P., Gardier, A. M., Sánchez, C., & Guiard, B. P. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3434-3 · Cited by 43 · see citing works

Control of the serotonergic system by the medial prefrontal cortex: Potential role in the etiology of PTSD and depressive disorders

Celada, P., Puig, M. V., Martín‐Ruiz, R., Casanovas, J. M., & Artigas, F. (2002) · Neurotoxicity Research · doi:10.1080/10298420290030550 · Cited by 39 · see citing works

[3H]WB4101 labels S1 serotonin receptors in rat cerebral cortex

Norman, A. B., Battaglia, G., Morrow, A. L., & Creese, I. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90743-x · Cited by 38 · see citing works

Comparison of Chlorpromazine, Haloperidol and Pimozide in the Treatment of Phencyclidine Psychosis: Da-2 Receptor Specificity

Giannini, A. J., Nageotte, C., Loiselle, R. H., Malone, D. A., & Price, W. A. (1984) · Journal of Toxicology Clinical Toxicology · doi:10.3109/15563658408992586 · Cited by 36 · see citing works

Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission

Haddjeri, N., Ortemann, C., de Montigny, C., & Blier, P. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00020-6 · Cited by 36 · see citing works

Comparison of the effects of LSD and lisuride on A10 dopamine neurons in the rat

White, F. J., & Wang, R. Y. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90089-8 · Cited by 27 · see citing works

Interaction between LSD and dopamine D2/3 binding sites in pig brain

Minuzzi, L., Nomikos, G. G., Wade, M. R., Jensen, S. B., Olsen, A. K., & Cumming, P. (2005) · Synapse · doi:10.1002/syn.20141 · Cited by 26 · see citing works

Hallucinogenic drug research— if so, so what?: Symposium summary and commentary

Freedman, D. X. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90371-0 · Cited by 25 · see citing works

Trace amines and their relevance to psychiatry and neurology: a brief overview / Eser aminler ve psikiyatri ve nöroloji ile ilişkisi: Kısa bir gözden geçirme

Narang, D., Tomlinson, S. E., Holt, A., Mousseau, D. D., & Baker, G. B. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5350/kpb-bcp201121113 · Cited by 23 · see citing works

Trace amines and their relevance to psychiatry and neurology: a brief overview

Narang, D., Tomlinson, S. E., Holt, A., Mousseau, D. D., & Baker, G. B. (2011) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20110403020951 · Cited by 20 · see citing works

Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex

Labonté, B., Bambico, F. R., & Gobbi, G. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0446-4 · Cited by 17 · see citing works

Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal

Gobbi, G., Muntoni, A. L., Gessa, G. L., & Diana, M. (2001) · Psychopharmacology · doi:10.1007/s002130100832 · Cited by 13 · see citing works

LSD Flashbacks

Hoffman, J. A. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790170105015 · Cited by 7 · see citing works

Lysergic acid diethylamide intoxication.

Matthew, H. (1968) · BMJ · doi:10.1136/bmj.1.5588.380 · Cited by 5 · see citing works

LSD and Schizophrenia-Reply

Vardy, M. M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790170105014 · Cited by 2 · see citing works

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506 · see citing works

Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor

Preller, K. H., Burt, J. B., Ji, J. L., Schleifer, C. H., Adkinson, B. D., Stämpfli, P., Seifritz, E., Repovs, G., Krystal, J. H., Murray, J. D., et al. (2018) · eLife · doi:10.7554/elife.35082 · Cited by 390 · see citing works

The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation

Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., Liechti, M. E., Seifritz, E., & Vollenweider, F. X. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.030 · Cited by 402 · see citing works

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

Gregorio, D. D., Aguilar‐Valles, A., Preller, K. H., Heifets, B. D., Hibicke, M., Mitchell, J., & Gobbi, G. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1659-20.2020 · Cited by 261 · see citing works

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works

Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review

van Elk, M., & Yaden, D. B. (2022) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104793 · Cited by 221 · see citing works

Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation

Krähenmann, R., Pokorný, D., Vollenweider, L., Preller, K. H., Pokorny, T., Seifritz, E., & Vollenweider, F. X. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4610-0 · Cited by 177 · see citing works

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155 · see citing works

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission

De Gregorio, D., Popic, J., Enns, J. P., Inserra, A., Skalecka, A., Markopoulos, A., Posa, L., Lopez-Canul, M., He, Q., Lafferty, C. K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020705118 · Cited by 139 · see citing works

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

Gregorio, D. D., Comai, S., Posa, L., & Gobbi, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111953 · Cited by 124 · see citing works

Preliminary Report on the Effects of a Low Dose of LSD on Resting-State Amygdala Functional Connectivity

Bershad, A. K., Preller, K. H., Lee, R., Keedy, S., Wren-Jarvis, J., Bremmer, M. P., & de Wit, H. (2019) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.12.007 · Cited by 95 · see citing works

d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders

Gregorio, D. D., Enns, J. P., Núñez, N. A., Posa, L., & Gobbi, G. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.07.008 · Cited by 92 · see citing works

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Ramaekers, J. G., Hutten, N. R. P. W., Mason, N. L., Dolder, P. C., Theunissen, E. L., Holze, F., Liechti, M. E., Feilding, A., & Kuypers, K. P. C. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120940937 · Cited by 92 · see citing works

Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline

Gregorio, D. D., Inserra, A., Enns, J. P., Markopoulos, A., Pileggi, M., Rahimy, Y. E., López-Canul, M., Comai, S., & Gobbi, G. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01301-9 · Cited by 88 · see citing works

Acute psilocybin enhances cognitive flexibility in rats

Pacheco, A. T., Olson, R. J., Garza, G., & Moghaddam, B. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01545-z · Cited by 90 · see citing works

Role of the 5-HT_2AReceptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study

Preller, K. H., Schilbach, L., Pokorny, T., Flemming, J., Seifritz, E., & Vollenweider, F. X. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1939-17.2018 · Cited by 71 · see citing works

Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective

Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works

Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment

Johnston, J. N., Kadriu, B., Allen, J., Gilbert, J. R., Henter, I. D., & Zarate, C. A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109422 · Cited by 68 · see citing works

Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches

Kantrowitz, J. T. (2020) · CNS Drugs · doi:10.1007/s40263-020-00752-2 · Cited by 66 · see citing works

Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications

Shahar, O., Botvinnik, A., Esh-Zuntz, N., Brownstien, M., Wolf, R., Lotan, A., Wolf, G., Lerer, B., & Lifschytz, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214148 · Cited by 61 · see citing works

Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activity

Glazer, J. E., Murray, C. H., Nusslock, R., Lee, R., & de Wit, H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01479-y · Cited by 56 · see citing works

Serotonergic Psychedelics - a Comparative review Comparing the Efficacy, Safety, Pharmacokinetics and Binding Profile of Serotonergic Psychedelics.

Holze, F., Singh, N., Liechti, M., & D'Souza, D. (2024) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.01.007 · Cited by 44 · see citing works

The Pharmacology of Visual Hallucinations in Synucleinopathies

Russo, M., Carrarini, C., Dono, F., Rispoli, M. G., Pietro, M. D., Stefano, V. D., Ferri, L., Bonanni, L., Sensi, S. L., & ONOFRJ, M. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01379 · Cited by 56 · see citing works

Exploring DMT: Endogenous role and therapeutic potential

Schimmelpfennig, J., & Jankowiak-Siuda, K. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110314 · Cited by 54 · see citing works

Lysergic Acid Diethylamide and Psilocybin for the Management of Patients with Persistent Pain: a Potential Role?

Whelan, A., & Johnson, M. I. (2018) · Pain Management · doi:10.2217/pmt-2017-0068 · Cited by 51 · see citing works

Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action

Canal, C. E. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_107 · Cited by 48 · see citing works

Molecular and Functional Imaging Studies of Psychedelic Drug Action in Animals and Humans.

Cumming, P., Scheidegger, M., Dornbierer, D., Palner, M., Quednow, B. B., & Martin-Soelch, C. (2021) · Molecules · doi:10.3390/molecules26092451 · Cited by 43 · see citing works

Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents

Jaster, A. M., Elder, H., Marsh, S. A., Revenga, M. D. L. F., Negus, S. S., & González‐Maeso, J. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06092-x · Cited by 44 · see citing works

The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics

Onofrj, M., Russo, M., Delli Pizzi, S., De Gregorio, D., Inserra, A., Gobbi, G., & Sensi, S. L. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02691-0 · Cited by 43 · see citing works

TAAR1 in Addiction: Looking Beyond the Tip of the Iceberg

Liu, J., & Li, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00279 · Cited by 43 · see citing works

Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD

Lawn, T., Dipasquale, O., Vamvakas, A., Tsougos, I., Mehta, M. A., & Howard, M. A. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06117-5 · Cited by 39 · see citing works

Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome

Inserra, A., Giorgini, G., Lacroix, S., Bertazzo, A., Choo, J. M., Markopolous, A., Grant, E., Abolghasemi, A., Gregorio, D. D., Flamand, N., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15977 · Cited by 40 · see citing works

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice

Inserra, A., Gregorio, D. D., Rezai, T., López-Canul, M., Comai, S., & Gobbi, G. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121991569 · Cited by 41 · see citing works

Are psychedelics the answer to chronic pain: A review of current literature

Kooijman, N. I., Willegers, T., Reuser, A. M., Mulleners, W. M., Kramers, C., Vissers, K. C. P., & van der Wal, S. E. I. (2023) · Pain Practice · doi:10.1111/papr.13203 · Cited by 43 · see citing works

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder

Markopoulos, A., Inserra, A., De Gregorio, D., & Gobbi, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749068 · Cited by 46 · see citing works

Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential

Allen, J., Dames, S., Foldi, C. J., & Shultz, S. R. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02360-0 · Cited by 38 · see citing works

Scoping Review: The Role of Psychedelics in the Management of Chronic Pain

Robinson, C. L., Fonseca, A., Diejomaoh, E. M., D'Souza, R. S., Schatman, M. E., Orhurhu, V., & Emerick, T. D. (2024) · Journal of Pain Research · doi:10.2147/jpr.s439348 · Cited by 38 · see citing works

Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis

Dourron, H. M., Strauss, C. K., & Hendricks, P. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000514 · Cited by 31 · see citing works

Serotonin/dopamine interaction: Electrophysiological and neurochemical evidence

Deurwaerdère, P. D., Chagraoui, A., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.02.001 · Cited by 36 · see citing works

The Effects of Psychedelics on Neuronal Physiology

Hatzipantelis, C. J., & Olson, D. E. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042022-020923 · Cited by 32 · see citing works

Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs

Cieślik, P., Woźniak, M., Kaczorowska, K., Brański, P., Burnat, G., Chocyk, A., Bobula, B., Gruca, P., Litwa, E., Pałucha-Poniewiera, A., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00316 · Cited by 32 · see citing works

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways

Sinha, J. K., Trisal, A., Ghosh, S., Gupta, S., Singh, D. K. K., Han, S. S., Mahapatra, M., Abomughaid, M. M., Abomughayedh, A. M., Almutary, A. G., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102211 · Cited by 31 · see citing works

TAAR1 as an emerging target for the treatment of psychiatric disorders

Liu, J., Wu, R., & Li, J. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108580 · Cited by 31 · see citing works

Beyond dopamine: Novel strategies for schizophrenia treatment

Dudzik, P., Lustyk, K., & Pytka, K. (2024) · Medicinal Research Reviews · doi:10.1002/med.22042 · Cited by 30 · see citing works

Molecular targets of psychedelic‐induced plasticity

Jaster, A. M., Revenga, M. D. L. F., & González‐Maeso, J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15536 · Cited by 30 · see citing works

A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics

Banushi, B., & Polito, V. (2023) · Biology · doi:10.3390/biology12111380 · Cited by 25 · see citing works

Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats

Grinchii, D., Hoener, M. C., Khoury, T., Dekhtiarenko, R., Bervanlou, R. N., Ježová, D., & Dremencov, E. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01739-9 · Cited by 28 · see citing works

Ketamine induces multiple individually distinct whole-brain functional connectivity signatures

Moujaes, F., Ji, J. L., Rahmati, M., Burt, J. B., Schleifer, C. H., Adkinson, B. D., Savić, A., Santamauro, N. P., Tamayo, Z., Diehl, C., et al. (2024) · eLife · doi:10.7554/elife.84173 · Cited by 27 · see citing works

Inter-individual variability in neural response to low doses of LSD

Hutten, N. R. P. W., Quaedflieg, C. W. E. M., Mason, N. L., Theunissen, E. L., Liechti, M. E., Duthaler, U., Kuypers, K. P. C., Bonnelle, V., Feilding, A., & Ramaekers, J. G. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03013-8 · Cited by 21 · see citing works

Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation

Moujaes, F., Rieser, N. M., Phillips, C. L. M., de Matos, N. M. P., Brügger, M., Duerler, P., Smigielski, L., Stämpfli, P., Seifritz, E., Vollenweider, F. X., et al. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.07.003 · Cited by 20 · see citing works

Modulation of long-term potentiation following microdoses of LSD captured by thalamo-cortical modelling in a randomised, controlled trial

Murphy, R. J., Godfrey, K. E. M., Shaw, A. D., Muthukumaraswamy, S. D., & Sumner, R. L. (2024) · BMC Neuroscience · doi:10.1186/s12868-024-00844-5 · Cited by 19 · see citing works

Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence

Inserra, A., Piot, A., Gregorio, D. D., & Gobbi, G. (2023) · CNS Drugs · doi:10.1007/s40263-023-01008-5 · Cited by 17 · see citing works

Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies

Armstrong, M., Castellanos, J. P., & Christie, D. (2024) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1346053 · Cited by 17 · see citing works

Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits

Sun, M., Zhang, Y., Zhang, X., Zhang, Y., Wang, X., Li, J., Si, T., & Su, Y. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01866-7 · Cited by 16 · see citing works

Females in Psychedelic Research: A Perspective for Advancing Research and Practice

Cohen, Z. Z., & Blest‐Hopley, G. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00255 · Cited by 15 · see citing works

The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules

Jiang, K., Zheng, Y. Y., Zeng, L., Wang, L., Li, F., Pu, J., Lu, Y., Zhao, S., & Xu, F. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114505 · Cited by 15 · see citing works

Psychedelics and schizophrenia: a double-edged sword

Sapienza, J., Martini, F., Comai, S., Cavallaro, R., Spangaro, M., Gregorio, D. D., & Bosia, M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02743-x · Cited by 15 · see citing works

Dysfunction of the serotonergic system in the brain of synapsin triple knockout mice is associated with behavioral abnormalities resembling synapsin-related human pathologies

Mazzocco, M. T., Guarnieri, F. C., Monzani, E., Benfenati, F., Valtorta, F., & Comai, S. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110135 · Cited by 15 · see citing works

Dose-dependent LSD effects on cortical/thalamic and cerebellar activity: brain oxygen level–dependent fMRI study in awake rats

Ghaw, A., Chunduri, A., Chang, A., Ortiz, R. J., Kozlowska, M., Kulkarni, P. P., & Ferris, C. F. (2024) · Brain Communications · doi:10.1093/braincomms/fcae194 · Cited by 13 · see citing works

LSD's rapid antidepressant effects are modulated by 5-HT2B receptors

Bouloufa, A., Delcourte, S., Rovera, R., Delannay, T., Duquet, A., Moulédous, L., Dkhissi‐Benyahya, O., Guiard, B. P., & Haddjeri, N. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118348 · Cited by 12 · see citing works

Unveiling GABA and Serotonin Interactions During Neurodevelopment to Re-Open Adult Critical Periods for Neuropsychiatric Disorders

Beretta, E., Cuboni, G., & Deidda, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125508 · Cited by 12 · see citing works

Behavioral Effects of a Potential Novel TAAR1 Antagonist

Lam, V. M., Mielnik, C. A., Baimel, C., Beerepoot, P., Espinoza, S., Sukhanov, I., Horsfall, W., Gainetdinov, R. R., Borgland, S. L., Ramsey, A. J., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00953 · Cited by 12 · see citing works

Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures

Yao, H., Wang, X., Chi, J., Chen, H., Liu, Y., Jiayi, Y., Yu, J., Ruan, Y., Xiang, X., Pi, J., et al. (2024) · Molecules · doi:10.3390/molecules29050964 · Cited by 11 · see citing works

Hopelessness, Suicidality, and Co-Occurring Substance Use among Adolescent Hallucinogen Users—A National Survey Study

Desai, S. R., Jain, V., Xavier, S., & Du, W. (2022) · Children · doi:10.3390/children9121906 · Cited by 9 · see citing works

Psychoactive substances for the treatment of neuropsychiatric disorders

Zhen, Z., Sun, X., Yuan, S., & Zhang, J. (2024) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2024.104193 · Cited by 9 · see citing works

Classical psychedelics’ action on brain monoaminergic systems

Butler, J. J., Ricci, D., Aman, C., Beyeler, A., & Deurwaerdère, P. D. (2024) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2024.106669 · Cited by 9 · see citing works

Developmental changes in brain structure and function following exposure to oral LSD during adolescence

Harris-Blum, L., Smith, Z., Ortiz, R. J., Athreya, D., Chang, A., Kulkarni, P. P., & Ferris, C. F. (2024) · Scientific Reports · doi:10.1038/s41598-024-69597-9 · Cited by 8 · see citing works

Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling

Grossi, G., Scarano, N., Musumeci, F., Tonelli, M., Kanov, E. V., Carbone, A., Fossa, P., Gainetdinov, R. R., Cichero, E., & Schenone, S. (2024) · Molecules · doi:10.3390/molecules29081739 · Cited by 8 · see citing works

Can Psychedelics be the Treatment for the Crisis in Psychopharmacology?Preprint

Oña, G., & Bouso, J. C. (2019) · Preprints.org · doi:10.20944/preprints201901.0249.v1 · Cited by 8 · see citing works

Biased Signaling in Psychedelic Action

Wacker, D., & McCorvy, J. D. (2025) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-062124-012545 · Cited by 8 · see citing works

Exploring the therapeutic potential of psychedelics in treating substance use disorders

Li, Y., Li, H., Wang, H., & Wang, X. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03168-w · Cited by 6 · see citing works

Eligibility for psychedelic therapy: Clinical trial medical exclusion criteria and their implications for hospital practice

Williams, M. L., Hitchcock, K. I., Miller, A. H., & Beck, S. A. (2025) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2025.12.009 · Cited by 7 · see citing works

Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine

Schwartz, M. D., Palmerston, J. B., Lee, D. L., Hoener, M. C., & Kilduff, T. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00035 · Cited by 7 · see citing works

5-HT2A receptors shape whole-brain monoaminergic coherence in male mice

Butler, J. J., Virgili, M., Giovanni, G. D., Chagraoui, A., Beyeler, A., & Deurwaerdère, P. D. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111437 · Cited by 6 · see citing works

Human pluripotent stem cells as a translational toolkit in psychedelic research in vitro

Salerno, J. A., & Rehen, S. K. (2024) · iScience · doi:10.1016/j.isci.2024.109631 · Cited by 6 · see citing works

The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field

Syed, O. A., Petranker, R., & Tsang, B. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106204 · Cited by 6 · see citing works

Transcriptomic Analysis of Glycosylation and Neuroregulatory Pathways in Rodent Models in Response to Psychedelic Molecules

Oommen, A. M., Roberts, K. J., Joshi, L., & Cunningham, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021200 · Cited by 6 · see citing works

Psychedelic Medicines in Major Depression: Progress and Future Challenges

Bouso, J. C., Oña, G., SANTOS, R. G. D., & Hallak, J. E. C. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6044-0_26 · Cited by 6 · see citing works

Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model

Kandilakis, C. L., & Papatheodoropoulos, C. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00892 · Cited by 4 · see citing works

LSD: Mechanisms and relevance to the treatment of depression

Bouloufa, A., Delcourte, S., Delannay, T., Rovera, R., Lau, T., Moulédous, L., Dkhissi‐Benyahya, O., Guiard, B. P., & Haddjeri, N. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106407 · Cited by 4 · see citing works

Lysergic Acid Diethylamide Alters the Effects of Brain Stimulation in Rodents

Dwiel, L. L., Henricks, A. M., Bragg, E. M., Nicol, J., Gui, J., & Doucette, W. T. (2023) · Psychedelic Medicine · doi:10.1089/psymed.2022.0014 · Cited by 4 · see citing works

LSD microdosing attenuates the impact of temporal priors in time perceptionPreprint

Sadibolova, R., Murray-Lawson, C., Family, N., Williams, L. T. J., Luke, D. P., & Terhune, D. (2023) · bioRxiv · doi:10.1101/2023.04.14.536983 · Cited by 3 · see citing works

Molecular brain imaging of psychedelic action

Cumming, P. D., Egger, K., & Knudsen, G. M. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.02.005 · Cited by 3 · see citing works

A bibliometric analysis of research on psychedelics for depression treatment

Hua, H., Fu, X., Wang, W., Wang, S., Wang, D., Wu, Z., Zhang, Q., He, T., & Yang, C. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36886 · Cited by 3 · see citing works

Addictive neurons.

Kodirov, S. A. (2017) · PubMed · Cited by 3 · see citing works

Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior

Richardson, B., Inserra, A., Pileggi, M., Prud’Homme, T., Bruno, V., Wan-Yan-Chan, D., Shareghi-Ghahreman, I., Nasini, S., Strand, T., Leyton, M., et al. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111522 · Cited by 2 · see citing works

The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects

Luethi, D., Glatfelter, G. C., Pottie, E., Sellitti, F., Maitland, A. D., Gonzalez, N. R., Kryszak, L. A., Jackson, S. N., Hoener, M. C., Stove, C. P., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03325-1 · Cited by 2 · see citing works

Lysergic Acid Diethylamide as an Analgesic Agent in Patients with Terminal Illnesses

Das, S., & Maiti, T. (2019) · Pain Management · doi:10.2217/pmt-2019-0043 · Cited by 2 · see citing works

Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review

Sabé, M., Grof, P., Sackett, N. B., Tai, S., Kryskow, P., Bershad, A. K., Turkington, D., Buonarroti, M., Pieri, M. D., Baniotopoulos, P., et al. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.03.003 · Cited by 1 · see citing works

Pharmacological Action of LSD

Herian, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_131-2 · Cited by 1 · see citing works

Medical Use of Cannabinoids and Psychedelic Compounds

Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1 · see citing works

Pharmacological Action of LSD

Herian, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_131 · Cited by 1 · see citing works

Medicines to Enhance Self-Consciousness, Mindfulness and Healthy Ageing?

Guertin, P. A. (2019) · Gerontology & Geriatrics Studies · doi:10.31031/ggs.2018.04.000587

P.668 Lysergic acid diethylamide (LSD) modulates social behavior and neuronal activity of pyramidal neurons in the medial prefrontal cortex

Inserra, A., Markopoulos, A., Gregorio, D. D., & Gobbi, G. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.491

Pharmacological Action of LSD

Herian, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_131-1

Medicines to Enhance Self-Consciousness, Mindfulness and Healthy Ageing?

Guertin, P. A. (2019) · Gerontology & Geriatrics Studies · doi:10.31031/ggs.2019.04.000587

Pathophysiology, Molecular Interaction Mechanism, Metabolism, Pharmacotherapy and New Perspectives in the Pharmacological Treatment of Chemical Dependence on the Main Illicit Drugs Consumed in the World

Ferreira, J. V., Chaves, G. A., Batista, M. A., Correia, L. C., de Souza, L. R., da Costa, D. C., Barcelos, M. P., da Silva, C. H. T. D. P., Taft, C. A., & Hage-Melim, L. I. D. S. (2022) · Engineering materials · doi:10.1007/978-3-031-07622-0_16

ПРОБЛЕМА УПОТРЕБЛЕНИЯ ПСИХОАКТИВНЫХ ВЕЩЕСТВ В ПЕДИАТРИЧЕСКОЙ ПРАКТИКЕ: СОМАТИЧЕСКИЕ АСПЕКТЫ. ОБЗОР ЛИТЕРАТУРЫ

Жумашева, А. С., Прилуцкая, М. В., Шарапатова, К. Г., Алтыбаева, Г. К., Шамарданова, О. М., & Kussainov, A. (2024) · Farmaciâ Kazahstana · doi:10.53511/pharmkaz.2024.89.95.018

Medical Use of Cannabinoids and Psychedelic Compounds

Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2

LSD (Lysergic Acid Diethylamide)

Krishnan, J. (2024) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815223828124010005

PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors

Gregorio, D. D., Posa, L., Ochoa‐Sanchez, R., McLaughlin, R. J., Maione, S., Comai, S., & Gobbi, G. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw041.361

[3H]WB4101 labels S1 serotonin receptors in rat cerebral cortex

Norman, A. B., Battaglia, G., Morrow, A. L., & Creese, I. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90743-x · Cited by 38 · see citing works

The Biochemistry of functional and experimental psychoses

(1973) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(73)90030-5 · Cited by 38 · see citing works

Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine

Kostowski, W., Gumulka, W. S., & Członkowski, A. (1972) · Brain Research · doi:10.1016/0006-8993(72)90208-9 · Cited by 125 · see citing works

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology

Gregorio, D. D., Comai, S., Posa, L., & Gobbi, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17111953 · Cited by 124 · see citing works